| abstract |
The present invention relates to antibodies that bind CD33. More particularly, the invention relates to anti-CD33 antibodies, fragments and homologs of said antibodies, humanized and coated versions of said antibodies, functional equivalents and improved versions of said antibodies, immunoconjugates and compositions comprising said antibodies and the use of the same in the diagnosis, research and therapeutic applications. The invention also relates to a polynucleotide encoding antibodies, vectors comprising polynucleotides, host cells transformed with polynucleotides and methods for producing antibodies. |